Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Heart Failure, Systolic

• Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
• Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
• Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction
• Levosimendan In Ambulatory Heart Failure Patients
• Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In Cardiac Disease
• Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS®
• Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
• Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure
• Growth Hormone in Ischemic Heart Failure
• The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation
• Iron in Patients With Cardiovascular Disease
• A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure
• COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure
• Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure
• Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker
• Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2
• Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations
• Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin
• Study of Dapansutrile Capsules in Heart Failure
• Nicotinamide Riboside in Systolic Heart Failure
• Prophylactic Lisinopril to Prevent Anthracycline Cardiomyopathy.
• Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure
• Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
• Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease
• Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
• Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia
• Pulse Reduction On Beta-blocker and Ivabradine Therapy
• Treatment of Diabetes in Patients With Systolic Heart Failure
• Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure
• Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
• Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure
• GutHeart: Targeting Gut Microbiota to Treat Heart Failure
• Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism
• Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets （FIRST）
• Evaluation of Cardiotoxic Effects of Bortezomib
• Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
• Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure
• Platelet Inhibition in Patients With Systolic Heart Failure
• Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Chronic Systolic Heart Failure
• Study of Efficacy on Cardiac Remodeling of Recombinant Human Neuregulin-1 in Stable Chronic Systolic Heart Failure Patients
• Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure
• A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure
• A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea
• Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure
• Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy
• A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines